@quadrapole.bsky.social
SBIR language was not included (yet). Any sense on where that stands?
December 8, 2025 at 6:46 PM
SBIR language was not included (yet). Any sense on where that stands?
* Promote broad distribution and geographic balance of funding, considering the total amount and type of NIH funding already available to each investigator
*Align with the availability of ICO funds
(3/3)
*Align with the availability of ICO funds
(3/3)
December 5, 2025 at 9:49 PM
* Promote broad distribution and geographic balance of funding, considering the total amount and type of NIH funding already available to each investigator
*Align with the availability of ICO funds
(3/3)
*Align with the availability of ICO funds
(3/3)
* Integrate a breadth of topics and approaches
* Consider investigator career stage and promote sustainability of the biomedical research workforce
(2/3)
* Consider investigator career stage and promote sustainability of the biomedical research workforce
(2/3)
December 5, 2025 at 9:49 PM
* Integrate a breadth of topics and approaches
* Consider investigator career stage and promote sustainability of the biomedical research workforce
(2/3)
* Consider investigator career stage and promote sustainability of the biomedical research workforce
(2/3)
Or at least parts of it.
November 21, 2025 at 3:50 PM
Or at least parts of it.
It gets worse... The Innovate Act wants to limit a company to a single P2 application submission per year, and two P1 applications. Not awards, but applications... which are mostly not funded. They also want to cap the number of submissions by a PI to a painfully small number. It kills the program.
November 19, 2025 at 8:45 PM
It gets worse... The Innovate Act wants to limit a company to a single P2 application submission per year, and two P1 applications. Not awards, but applications... which are mostly not funded. They also want to cap the number of submissions by a PI to a painfully small number. It kills the program.